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Translation is responsible for the production of all proteins in a cell making it crucial 
to the survival of all organisms. Translation involves the decoding of an mRNA by 
ribosomes and tRNAs. Studying tRNA-ribosome interactions in detail is important for 
modelling protein synthesis, and this has applications in bioprocessing and in 
understanding gene regulation in diseases. 
This project has set out to develop a single molecule technique to image each step 
of the ribosome:tRNA interaction process. This will enable studying the rate at which 
translation occurs as well as further define the steps that characterise this process. I 
have designed and cloned a synthetic DNA sequence which can be used to initiate 
translation in in vitro reactions. By omitting leucine from the translation reaction, 
ribosomes can be arrested at a specific leucine codon in a state where a six histidine 
tag protrudes from the ribosomal exit channel. This should enable immobilisation of 
translating ribosomes on metal-affinity surfaces. The functionality of the synthetic 
sequence was demonstrated in a reticulocyte lysate system. A complementary 
detection system that allows localising individual ribosome:mRNA complexes is 
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DNA: Deoxyribonucleic acid 
RNA: Ribonucleic acid 
mRNA: Messenger Ribonucleic acid 
tRNA: Transfer Ribonucleic acid 
IF: Initiation Factor 
EF: Elongation Factor 
GTP: Guanosine Triphosphate 
A/T/G/C: Adenine/Thymine/Guanine/Cytosine 
CCD: charge coupled device 
CMOS: complementary metal oxide semiconductor 
PCR: Polymerase chain reaction 
LB: Luria Broth 




This project sought to develop new, novel reagents in the pursuit of understanding 
Translation in a single molecule system. In turn, this would allow research to be 
conducted on a single molecule level, in real time, in an effort to resolve the 
questions surrounding the rates of Translation and its control. 
In order to progress in this area, it is important that a sound knowledge of Translation 
and its preceding events is shown, so that when we ultimately focus on this area, it is 
clear what is being investigated.  
One of the steps preceding translation, is transcription. Transcription is the 
conversion of the double stranded DNA molecule (which contains the required gene) 
into a single stranded messenger RNA (mRNA) molecule.  The DNA is unzipped and 
RNA Polymerase II will catalyse the formation of mRNA through complimentary base 
pairing. This mRNA molecule now contains a copy of the gene and must be 
translated into a protein. 
In Eukaryotes, this occurs in distinctly separate steps, where the mRNA will be 
exported from the nucleus of the cell and to a Ribosome to undergo Translation. 
However, in Prokaryotes, the process of transcription and translation will occur 
simultaneously as the genetic material is not kept within a nucleus.  
The focus points of this project are the final steps of this process that are completed 
during Translation and how this system can be affected in a negative way. It is 
therefore important that an overview of Translation is given in order to understand 
how it was tested. Translation occurs in 3 distinct stages: 
1. Initiation 
This step begins with the formation of a complex with the smaller, 30S subunit of the 
Ribosome. First, three different initiation factors bind to the smaller subunit of the 
Ribosome (IF1, IF2 and IF3) which along with a tRNA carrying Methionine, bind to 
the mRNA sequence at the AUG start codon. This complex is now ready to receive 
the larger 50S subunit of the Ribosome, which once bound, causes the release of 
the initiation factors1.  
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As described before and shown in Figure 1 the ribosome has 3 specific sites: Amino 












Now that translation has begun, the Ribosome has to move along the mRNA in order 
to read each codon that will form the rest of the protein. This movement occurs in a 
5’ to 3’ direction in a process called translocation. This movement will lead to the 
next tRNA (in a complex with Elongation factors and GTP as an energy source) 
entering the A site where GTP is cleaved into GDP and then released along with the 
Elongation factors for further use. In E.coli it is important to note that these 
Elongation Factors are known as EF-Tu and EF-Ts. 
Now that the correct amino acid has arrived in the Ribosome, a peptide bond must 
be formed with the previous amino acid, via the activity of Peptidyl Transferase. 
Once this bond has been formed, the Ribosome will translocate once more leading 
to the tRNA occupying the E site where it is then released to be used again. This 
process is completed until the STOP codon has been reached3. 
 
Figure 1. The large ribosomal subunit binds to the small ribosomal subunit to complete the initiation 
complex.The initiator tRNA molecule, carrying the methionine amino acid that will serve as the first amino 
acid of the polypeptide chain, is bound to the P site on the ribosome. The A site is aligned with the next 






Once any of the three STOP codons (UGA, UUA or UAG) are reached, will cause 
release factors to bind to the mRNA, removing it from the Ribosome and trigger the 
deconstruction the Ribosome. The Peptide can now be modified or used where it is 
needed4.  
 
Two of the biggest issues that we face in our understanding of Translation are its 
control and the subsequent ability to define a rate constant. These linked issues are 
difficult to understand for a multitude of reasons that individually are understood, but 
in an in vivo system are not due to complex interactions such as those between the 
Ribosome and cognate, near cognate and non-cognate tRNA.  
The prevailing thought on Translational control, particularly in the Elongation stage 
has long been that the degeneracy of the genetic code was insignificant in terms of 
gene function. As we know, the combination of 64 codons leads to the uptake of the 
20 amino acids vital for protein synthesis, however, recently the thought has 
somewhat changed to the idea that there can be “codon optimality” where 
synonymous codons are indeed recognised differently5. This is highly important as it 
suggests that we need to fully understand the parameters under which Translational 
elongation occurs in order to define a rate constant. The crux of Codon optimality is 
that although a set of codons translate to the same amino acid, there may be a 
particular codon of that set that is most optimal and hence can have an influence on 
the overall elongation rate6.  
Additionally, there are some other situations where Translation can be controlled, for 
example due to a low abundance of aminoacyl-tRNAs corresponding to the correct 
codon. Recent studies have aimed to expose a deeper understanding of the role of 
stress in regulating Translation, particular in the Elongation phase. Exposure of cells 
to hydrogen peroxide, which leads to stress, results in an increase of modified tRNA 
containing 5-methylcytosine (m5C) which in turn caused the selective translation of 




This stress directly lead to the reduction of activity confirmed by a dual Luciferase 
and Renilla construct by up to 9.6 times7, suggesting that in this case the overall rate 
of Translation would be influenced. 
 
One such area that may be important to further investigate is the role that post-
transcriptional modifications play in the coding region of mRNA. This has been 
demonstrated through N6-methylation of adenosine (which forms m6A) which 
disrupts tRNA selection during translation which in turn will disrupt the elongation 
step8. In tRNA, this modification is vital for its function, more importantly however in 
mRNA it can inhibit the decoding tRNA9. The interaction of one such m6A codon and 
the corresponding tRNA has been theorised to closely mirror that of a near cognate 
tRNA-codon interaction owing to the fact that the position of m6A within the codon 
will delay the incorporation of a tRNA. It was found that the location of the 
modification within the mRNA actually has an effect on the time that it takes for the 
cognate amino acid to be selected. When the modification appears earlier in the 
sequence, the delay is significantly larger than when it is further down (up to a 15fold 
difference for it being at the first codon). In addition to this, the surrounding bases do 
in fact play a role in mitigating or exacerbating this effect as shown through the 
translation of different codons (that give the same amino acid). For example, the 
Cm6AG glutamine codon showed a 5 fold increase in comparison to the CCm6A 
proline codon which only showed a 3 fold increase10.  
It is important to highlight that whilst this modification delays translation, it does not 
completely disrupt it and prevent it from taking place. For this reason m6A 
modifications could be an important regulator of translation as well as other 
processes such as cell viability. Moreover, regulation of the elongation rate of 







Complex interactions in Translation such as those described previously can be 
understood in full detail through the use of single molecule techniques, which will 
result in the ability to define a rate constant for Translation, which is a vital 
progression for computational analysis.  
Single molecule techniques found their origin in the study of ion channels12, 
spawning a large amount of tools that enable us to study an area of interest at the 
ensemble level allowing us to gain an insight into an entire process in great detail. 
This is achieved by exploring each individual pathway and providing a probability 
that this pathway will occur13. This is of particular importance as we explore ever 
more complex processes as we can get an entire view of a Biochemical reaction. As 
opposed to a normal Biochemical experiment, a single molecule experiment will 
enable the tracking of individual molecules which in turn can lead to the 
characterisation of not only the kinetics of the system, but also potential intermediate 
steps. This is coupled with the ability to not only photograph but also record the 
process in real time to gain a deeper understanding of our interpretation14. 
The overarching goal of using single molecule techniques in investigating translation 
is that it will enable us to watch the process occur in real time and as such analyse 
each individual step. Therefore we would be able to study a particular mechanism in 
great detail and quantify the complete reaction.  
While single molecule systems sound very attractive, they are not without their 
limitations. The most obvious of these is signal; due to the inherent lack of molecules 
in the system. Therefore it must be concluded that any amplification of this signal 
has to come from the apparatus that is being used (such as detectors). The entire 
way that these systems are monitored in real time has had to have been overhauled 
and improved. CCD and CMOS imaging cameras have been developed to produce 
images and recordings at a faster frame rate, which allow the system to be analysed 






In addition to this new fluorophores have been developed that are both more bright 
and photostable, thus delaying bleaching. An example of these are quantum dots 
(Qdots) which are both bright and photostable which makes them desirable for use in 
single molecule systems, allowing you to attach them to a molecule of interest and 
track them through the system16-18.   
If the parameters of Translation and its control can be fully understood using the 
aforementioned single molecule experiments, it would be possible to define a rate of 
Translation which would enable the use computational methods to predict the rate 
and model of a particular system of interest.  
Recent advances in computational analysis have yielded software with the ability to 
predict the outcome of a known open reading frame (ORF), with it outputting 
comprehensive data including errors and usage rates (of tRNA and codons) when a 
Ribosome has finished translation19. Such computational models are limited in their 
scope as they rely on assumptions such as the cognate (or near cognate) tRNAs 
being the only ones to bind to the Ribosome and as such cannot be used to 
accurately predict a rate for Translation. 
The development of single molecule systems to investigate Translation has been 
more heavily studied recently with new systems such as a SunTag Fluorescence 
tagging system being developed specifically to target Translation21. This particular 
system has been used to measure several stages of Translation including initiation 
and elongation uncovering more heterogeneity among different mRNA molecules22. 
Similarly to the system we have sought to begin developing, it can be applied to the 
visualisation of mRNA molecules and Translation in living cells. 
If we are able to reliably define a rate for Translation using single molecule 
experiments, it may be possible to shine some light on disease states within the cell 
associated with abnormalities in Translation. Recent studies have indicated that a 
form of neurodegeneration in mice can lead to Ribosome stalling as a result of 
particular mutated codons20. In this experiment the prevalence of the AGA codon 
was indicating a high amount of stalling which would lead to the premature release of 




This project sought to develop reagents that could be used in further translational 
studies. By developing these reagents, further research could be done to shed light 
on detailed rates of translation as well as its accuracy. Problems that it could help to 
solve include the accuracy of mRNA translation (tRNA competition, rejection of 
incorrect tRNA:Amino acid complexes, how the correct tRNA is identified and the 
rate of uptake of amino acid from the tRNA) as well the identifying the overall rate of 
translation in a developed single molecule system. 
This aim can be achieved by producing a stable DNA plasmid containing the gene 
for a well-documented and easy to analyse protein. In addition to this, the plasmid 
will need to contain suitable sequences for analysis and purification, such as a 6x 
Histidine tag, ensuring that it is a suitable distance from the protein, so that it will be 
in the exit tunnel of the Ribosome. Moreover, once the Plasmid has been produced, 
it will need to be verified via sequencing and the proteins activity quantified. 
Over the course of this thesis, I will demonstrate the techniques used in the design, 
refinement and verification of a fully functional Plasmid including cloning, DNA 
Agarose gel electrophoresis (and staining), DNA extraction/purification and 














(2) Materials and Methodology 
1. Initial Design 
The initial focus of the project centred on selecting a protein that is well documented 
and easy to work with. As the aim of the project is to analyse translation, it is 
important to use a protein that can be easily verified as active and for this purpose, 
Luciferase was selected. As we are editing an entire Plasmid for this analysis, we 
would excise the Luciferase gene from a separate Vector that had the gene for 
ampicillin resistance (PTH727). In addition to this, two spacers24 were designed 
(staCFluc_r_Hin and spac_staCFLuc_f – see appendix) which would ensure that the 
6x Histidine tag would be suitably exposed when completing translation analysis.  
These spacers ensured that the BamHI site would be upstream of the later inserted 




Figure 2. Schematic of the initial design of the Plasmid, focusing on key areas 
including: T7 Promotor, Kozak Sequence, Histidine tag, Spacers (as described in 
main body of text) and the Luciferase gene. Highlighted, is the Leucine codon at 
position 17 of Luciferase; this is the target of arrested translation. In addition to this 
note the erroneous inclusion of a second BamHI site in the designed spacers 
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We began the project by selecting the PTH727 plasmid, which had been used in 
other translational control experiments. This plasmid contained the vital Luciferase 
gene sequence that was desired to be used as our focus protein. This plasmid was 
known to have antibiotic resistance to Ampicillin and so any uptake of the plasmid by 
competent bacterial cells. 
1.1 Bacterial Transformation 
Initially, a bacterial transformation was used in order to produce cells containing the 
target Luciferase gene. 50 μl of competent E.coli were added to 1 μl of the plasmid 
and incubated for 20 minutes on ice. This mixture was then heat shocked at 42°C for 
60 seconds and then immediately returned to ice, where 1 ml of LB was added. This 
was incubated in a shaking incubator for at 37°C for 60 minutes to allow time for the 
bacterial cells to amplify. 100 μl of the resulting cells were plated onto an LB 
Ampicillin plate using full aseptic techniques, which was incubated at 37°C, overnight 
and inspected for colonies. 
The resulting colonies were used to inoculate 10 ml of LB ampicillin (one colony per 
inoculation) to amplify the cells for later purification. Using full aseptic technique, 
each colony was placed into a sterile aerated growth tube containing 10 ml of LB 
Ampicillin and incubated at 37°C, overnight in a shaking incubator (8 overnights took 
place). 
These inoculations were then pelleted at 8000rpm for 3 minutes at ambient 
temperature, where the supernatant was then discarded and the pellets collected for 
purification. 
The resultant pellets contained the Plasmids carrying the Luciferase gene and were 
purified using a QIAprep Spin Miniprep kit, according to the manufacturer’s 
guidelines. 
1.2 PCR Amplification of Luciferase 
The purified plasmid containing Luciferase was then used in PCR amplification along 
with the designed oligonucleotides which would incorporate a spacer sequence 
upstream of Luciferase (from the BamHI site) as well as a HinDIII site downstream of 




1 μl of the purified plasmid was mixed with 1 μl each of the primers 
(spac_staCFLuc_f and staCFLuc_r_Hin) and 25 μl of GoTaq green mastermix, for a 
total volume of 50 μl (including sterile water). 4 of these samples were produced and 
entered into a PCR profile to amplify the fragment (sequences in Table 1) 
 
Oligonucleotide Sequence (5’ – 3’) 
spac_staCFLuc_f GGGGGCGGATCCGGAGGGGGCGGGTCTGGCGGGGGCG 
GATCCGAAGACGCCAAAAACATAAAGAAAGGC (69) 




By checking the parameters of the primers, the PCR profile was designed to 
maximise the yield of the cloned fragment. Full cycles completed were 1x 
Denaturation (96°C/5 minutes) 30x Elongation (96°C/45 seconds, 50°C/45 seconds 
and 72°C/1 minute) and 1x Final Extension (72°C/5 minutes) with the samples being 
held at 5°C thereafter. 
1.3 DNA Agarose Gel and Purification 
In order to verify that the cloning was successful, a 1% agarose gel was made by 
mixing 0.5 g with 50 ml of 1% TAE buffer, with 1 μl of Ethidium Bromide being added 
as a dye for the DNA when visualised under UV light.  The resulting PCR samples 
were run on this gel at 80V for 45 minutes to ensure that full movement had 
occurred. 25 μl of DNA Hyperladder 1KB were used as a marker with the expectation 
that the cloned fragment would be around 500 base pairs in size. 
With 2 of the trials being successful (see Figure 3 in results section), we could now 
excise and purify these bands using a GeneJET Gel Extraction Kit as per the 
manufacturers guidelines. Care was taken to ensure that the gel samples were not 
exposed to UV light for a prolonged period as to avoid possible base mutations. 
Table 1. Table showing the sequence of the primers added to Luciferase to incorporate 
desired spacers. Numbers in brackets are the total number of bases per sequence 
listed in 5’ to 3’ order. Highlighted in bold are two BamHI recognition sequences, the 
second of which, was erroneously incorporated into the design. 
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Moreover, it was important to ensure that all of the gel containing the correct band 
was excised, and so this was done with a scalpel, with the gel being re-examined to 
check for any leftover DNA. 
 2. Preparation of modified PGEM 3ZF Plasmid 
2.1 Target vector Restriction Digest 
PGEM 3ZF was selected as the target vector owing to its multiple cloning region as 
well as suitable restriction enzyme sites that were crucial for the incorporating of 
extra genetic material. 
The target vector was digested at two important sites, between the forward and 
reverse primers, using BamHI-HF and EcorI-HF to ensure a correct and full 
digestion. The sample was prepared by mixing  15μl PGEM 3ZF with 1 μl EACH of 
BamHI-HF and EcorI-HF, in 4 μl Cutsmart Buffer. A total volume of 40 μl was given 
with the addition of sterile water. This was incubated for 2 hours at 37oC and then 
purified to remove the excess enzyme, using a PCR purification kit per the 
manufacturers guidelines. 
2.2 Annealing of oligonucleotides (for insertion) 
This would subsequently allow the insertion of more spacers (up_f and up_r) to be 
added to the target sequence insertion site. In addition to this, they would introduce 
the Kozak25 sequence elements up to the BamHI site in the spacers from our first 
fragment design. The Kozak sequence is highly important as it can have an effect on 
overall translation elongation rates26. (sequences in Table 2) 
These 2 oligonucleotides were annealed by mixing 2μl of each Oligonucleotide in 
10μl 10x Ligation Buffer for a total volume of 100 μl. 
This was then heated to 90°C for 5 minutes and then allowed to cool back to ambient 
temperature. Once cooled, the annealed oligonucleotides were diluted with 150μl 









2.3 PGEM 3ZF & Annealed Oligonucleotide Ligation 
With each of the separate samples prepared, they would now need to be ligated in 
order to incorporate the annealed oligonucleotides into the target vector. The ligation 
was prepared mixing 7μl of restriction digested vector (PGEM-3ZF) with 1 μl of 
annealed oligonucleotides, 1μl of T4 DNA Ligase and 1μl 10x Ligation buffer for a 
total volume of 10 μl. 
Alongside this, a control ligation was completed without the presence of annealed 
oligonucleotides, which were replaced with water. This control is of upmost 
importance as it allows us to compare between the two and if the vector is able to be 
used in a transformation (post restriction digest) even if the oligonucleotides are not 
incorporated. This will verify that antibiotic resistance has been conserved as well as 
check for any possible contamination. 
The 2 samples were mixed and incubated in a thermomixer overnight at 18oC in a 
cold room. After the ligation and subsequent purification of each sample, it was 
essential to test if the oligonucleotides had in fact been incorporated into the vector. 
This was done in a similar fashion to the transformations documented in section 1.1, 
however, in this case all 10 μl of the ligated Plasmid were used in the transformation. 
An overnight inoculation took place to amplify the bacterial colonies which were 
pelleted and purified as described in section 1.1 also. 





Table 2. Table showing the sequence of the primers added to PGEM 3ZF to 
incorporate desired spacers and sequences, including the highly important Kozak 
sequence. Numbers in brackets are the total number of bases per sequence listed in 5’ 
to 3’ order. 
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The purified Plasmid was run on a DNA agarose gel as per section 1.3 with the 
expectation of a large band close to the top of the gel at around 4500 base pairs, 
which would confirm that all of the spacers had been correctly inserted into the 
plasmid. 
 
2.4 Modified PGEM 3ZF & Modified Luciferase Ligation 
With the presence of a band at around 4500 base pairs, we now needed to ligate the 
modified luciferase gene into the target vector to complete the construction of the 
final product.  
2.4.1 Modified PGEM 3ZF & Luciferase Restriction Digest 
This was begun with a restriction digest of the modified PGEM 3ZF in the same 
fashion as described in section 2.1; with the exception that HinDIII was used in place 
of EcorRI to ensure that the Luciferase would be incorporated into the correct section 
of the plasmid. In addition to this, a double digest of 4 hours took place, to ensure as 
full a digest as possible had taken place. In order to ensure the correct incorporation 
of the Luciferase gene, the plasmid containing the gene was also digested with 
BamHI and HinDIII for 4 hours. 
 
With both constituent parts digested and purified, they were ligated together in the 
same fashion as described in section 2.4, with the annealed Oligonucleotides being 
replaced by the digested Luciferase fragment.  
In order to verify if a successful Ligation had occurred, the resultant sample was 
used in a transformation, overnight growth and purified. When run on an Agarose 
gel, a band of approximately 4700 base pairs was to be expected.  
 2.5 Sequence analysis 
As this 4700 base pair band was present, the samples were excised from the gel as 
described in section 1.3, purified and prepared for GATC sequencing using M13F 
and R primers. Sequencing would allow us to check if the construct had been 
successfully manufactured and if there were any issues. 
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3 samples were selected for sequencing and 6 total samples would be sent off as 
the entire target sequence was larger than would be accepted.  
Of the successful ligations, samples 1, 4 and 9 were selected, as these appeared to 
show the greatest chance of success. 5 μl of plasmid was mixed with 5 μl of primer 
(M13F and M13R) and sent off for analysis. 
3. Sequence Analysis and Repair 
 3.1 Identification of errors 
Once the sequencing data was received, multiple checks were used to identify if the 
construct had any errors and also to check the incorporation of all oligonucleotides. 
Upon analysis, it was found that there was a flaw in the original construct sequence 
that had gone unnoticed (see Figure 2 for second BamHI site labelled).  
This flaw had resulted in a deletion of vital bases that would need to be reinserted 
into the construct in order to move on in our experiment. The supporting data and the 














3.2 Plasmid repair 
The plasmid had to be prepared for the insertion of the new oligonucleotides in a 
way that would yield a good result. The new repair sequence had to re-insert the 
missing nucleotides lost as a result of digestion by BamHI. The missing information 
included vital spacers needed to ensure that the 6x Histidine tag was in the exit 
tunnel of the Ribosome when translation was arrested. 
The plasmid was prepared by a restriction digest as described in section 2.1, 
however, only BamHI was used. The resulting fragment was purified for repair using 
PCR. 
Initially, an attempt was made to repair the Plasmid using the BV_5 and BV_check 
Oligonucleotides. Having consulted the parameters of the repair sequences, PCR 
was completed using the same method described in section 1.2. However, sequence 
analysis of the resulting Plasmid revealed that the repair sequences were not 
incorporated correctly into the Plasmid. 
Another approach was attempted using the BV_3 repair oligonucleotide and M13F 
primer to insert the missing section of the sequence. These samples were once 
more run on an Agarose gel to test if we were successful. This was then sent off for 
sequencing to test if it was successful.  
Sequencing and the subsequent analysis revealed that the repair sequence had 
been incorporated into the Plasmid and there were enough Codons to ensure that 
the 6x Histidine tag would be positioned correctly. 
4. Initial Testing 
4.1 Initial testing (RNA synthesis) 
With the construct successfully completed, it was important to now establish its 
usefulness and if it could still be transcribed and translated to produce Luciferase 






Numerous factors would have to be considered for this to produce a viable volume of 
mRNA in a reliable manner. Issues included the addition of DTT to produce a 
reducing environment for the reaction27, the addition of RNAse inhibitor as well as 
the optimal time to maximise RNA synthesis. 
A preliminary test was conducted to assess the viability of in vitro Transcription in 
this case. The plasmid was linearised by a restriction digest using HinDIII only and 
purified to remove the enzyme. 10 μl of linearised DNA was mixed with 10 μl T7 
RNA Polymerase, 4 μl of 0.5 mM NTP (1 μl of each), 5 μl DTT and 10 μl of 10x 
buffer, for a total volume of 100 μl (including sterile water). A separate reaction was 
also conducted with the absence of DTT, which was replaced by water. 
The resulting samples were incubated at 37°C for 3 hours before being purified using 
an RNeasy Plus mini kit, following the manufacturers guidelines.  
4.1.1 Urea Gel electrophoresis 
In order to test the purified RNA, an Urea must be made as traditional DNA Agarose 
gels will not work in this case. 
For this test, a 6% Urea gel was made by mixing 22g of Urea with 10ml 5x TBE,  
7.5 ml Acrylamide/Bisacrylamide 40% (29:1) and sterile water to 50ml. Care was 
taken to ensure that all of the Urea had dissolved prior to adding 25 μl of 40% APS 
and 55 μl of TEMED to catalyse the polymerisation of the gel. 
The gel was run empty for 30 minutes at 20mA to raise the temperature of the gel 
system and the wells were also washed with 1x TBE buffer to remove excess Urea. 
32 μl of the RNA sample was mixed with 8 μl of fresh buffer (essential that it is free 
from nucleases)  and loaded onto the gel. The gel was run in 1x TBE buffer for 1 
hour (until the tracker dye had run) and stained in a solution of ethidium bromide. 
Upon visualising the gel under UV light, it became obvious that no RNA bands were 
present on the gel even after re-staining. 
Another 2 preliminary trials were attempted (and both failed) and so due to the large 
number of variables to control, it was decided that a coupled system of transcription 




5. Further Analysis 
5.1 Large scale Bacterial Transformation 
Before, any more tests were conducted; we needed to increase our stocks of the 
Plasmid so that we had a larger supply in reserve. 
The bacterial transformation was partly the same as used in section 1.1. 50 μl of 
competent E.coli were added to 1 μl of the plasmid and incubated for 20 minutes on 
ice. This mixture was then heat shocked at 42°C for 60 seconds and then 
immediately returned to ice, where 1 ml of LB was added. This was incubated in a 
shaking incubator for at 37°C for 60 minutes to allow time for the bacterial cells to 
amplify. 100 μl of the resulting cells were plated onto an LB Ampicillin plate using full 
aseptic techniques, which was incubated at 37°C, overnight and inspected for 
colonies. 
The resulting colonies were used to inoculate 50 ml of LB ampicillin (one colony per 
inoculation) to amplify the cells for later purification. Using full aseptic technique, 
each colony was placed into a sterile 250 ml conical flask containing 50 ml of LB 
Ampicillin, which was aerated and incubated at 37°C, overnight in a shaking 
incubator (2 overnights took place). 
These inoculations were then transferred to Falcon tubes and pelleted at 8000rpm 
for 3 minutes at 5°C, where the supernatant was then discarded and the pellets 
collected for purification. 
The resultant pellets contained the Plasmids carrying the Luciferase gene and were 
purified using a QIAprep Spin Midiprep kit, according to the manufacturer’s 
guidelines. This larger scale kit yielded a much higher volume, which was frozen to 








5.2 Luciferase Assays 
Knowing that the Plasmid had been constructed successfully, we now needed to 
verify the activity of the Luciferase gene. Following the failed RNA synthesis 
attempts, a T7 Coupled Reticulocyte Lysate System was used which would complete 
both transcription and translation simultaneously, allowing us to analyse the activity 
of Luciferase on its substrate. 
 
5.2.1 Confirming Luciferase activity 
The original (unedited) PGEM 3ZF was used to transform BL21 for the purposes of 
being a control for this assay, as well as the final edited Plasmid and then grown on 
an LB AMP plate. These bacterial transformations were completed in the same way 
as described in section 1.1 up to the inoculation stage, where a 96 well plate 
containing LB AMP was inoculated 3 times per sample and incubated at 37oC 
overnight, with one colony being harvested per well and grown in 150μl of LB AMP. 
In order to prevent any evaporation, the surrounding wells were filled with distilled 
water. 
With the samples prepared, they were now diluted 4 times (120μl of LB AMP mixed 
with 30μl of the overnight incubation) and incubated for 3 hours for the final growth. 
In order to conduct the assay itself, the manufacturer’s guidelines were followed 
exactly and once the substrate had been added to the wells, the plate was then 
placed in a plate reader to find the bioluminescence of the samples. The final data 
confirmed that the edited construct containing Luciferase was active, due to the 









5.2.2 Luciferase Assay, with arrested Translation 
As the data suggested that the construct could indeed produce Luciferase it was now 
important to test if translation could be arrested at a particular point. This idea had 
been built into the construct from initial design and would be tested by omitting 
Leucine from the amino acid mix used in the test. As this was Leucine was located 
within Luciferase, (and there were no other Leucine codons before it) translation 
would be arrested and the substrate would no longer be correctly digested (as 
Luciferase would not be produced). 
To test this fully, a control was set up containing the full amino acid mixture ensuring 
that Luciferase could be produced and the substrate digested. Measurement was 
once again taken via Bioluminescence, with the expectation being to compare 
arrested translation with the control. To ensure reliability, the test was completed in 
triplicate with a t-test being used to interpret the data. 
As shown in Figure 6 we can see an average of 162 for the –Leucine trial which is 
comparable with the background bioluminescence of the test. Therefore, this 
suggests that translation has been arrested, due to a lack of Bioluminescence when 
compared to the +Leucine trial which had an average reading of 571.6. 
However, further controls are needed to unequivocally prove this hypothesis and are 






 PCR Amplification of Luciferase 
The initial focus of the project was to gather samples of the desired Luciferase gene 
(in the PTH 727 plasmid) which could be further used in the construction of our final 
Plasmid. 
By editing the Plasmid, we could insert vital spacer sequences that would ensure 
that the 6x Histidine tag would protrude from the Ribosomal exit tunnel correctly.  
The design of the spac_staCFLuc_f oligonucleotide was actually flawed in the 
beginning and this was highlighted in Table x in section 1.2. When looking closely at 
the sequence, we can see the presence of two BamHI recognition sequences, 
characterised by the motif GATC. 
…GGATCCGGAGGGGGCGGGTCTGGCGGGGGCGGATCC… 
The incorporation of this second site would ultimately lead to the deletion of part of 
this spacer which would result in a shorter sequence. While this oversight is 
unfortunate, it was fortunately, not catastrophic and would later be repaired as 
discussed in the Plasmid Repair section. 
When these spacers were initially incorporated into the Plasmid via PCR, the 
expectation was to see a strong band of around 500 base pairs. This would indicate 
the successful uptake of the spacers by the Plasmid which could then be digested to 
release the crucial edited Luciferase fragment. 
In order to check for the incorporation of the spacers, a DNA Agarose Gel was used 
along with DNA markers indicating a Base pair size. In this case, DNA HyperLadder I 
was used as this contained two lower bands of 400 and 600 base pairs.  
With the gel run and visualised under UV light, it was apparent that trials 2 and 3 
were the most successful, with trial 4 showing a smaller band. In addition to this, trial 
1 showed no band at all and was considered to be negative. 
Highlighted in red on Figure 3 are the two successful trials which were excised and 
purified for further use in the project. Smaller bands are also visible on the bottom of 





Figure 3. Ethidium Bromide stain of a DNA Agarose Gel for modified Luciferase Gene 
(including spacers). Samples were prepared via PCR where they contained GoTaq 
master mix including green dye. Full cycles completed were 1x Denaturation (96oC/5 
minutes) 30x Elongation (96oC/45 seconds, 50oC/45 seconds and 72oC/1 minute) and 
1x Final Extension (72oC/5 minutes) with the samples being held at 5oC thereafter. 
Each 50μl sample was loaded into a well on a 1% Agarose gel which was run at 80V 
for 45 minutes. Our sample was expected to be ~500bp in size and two successful 
samples are highlighted in the red boxes. The gel was visualised under UV light and 









PGEM 3ZF & Annealed Oligonucleotide Ligation 
With the confirmation that the Luciferase containing Plasmid had been successfully 
edited, we moved onto preparing PGEM 3ZF for the insertion of the Luciferase 
fragment. 
This began with a restriction digest of the Plasmid to prepare for the insertion of 
more oligonucleotides, which would also incorporate the Kozak and His tag 
sequences. The oligonucleotides would ultimately reside upstream of the BamHI site 
inserted before the Luciferase gene. 
This set of oligonucleotides were inserted via a Ligation of our target vector and the 
annealed oligonucleotides; moreover, this step had to be completed prior to the 
insertion of the Luciferase sequence. 
 
In order to verify the insertion of these oligonucleotides, the resulting Ligation was 
used in a bacterial transformation, which was purified and tested on a DNA Agarose 
gel. DNA HyperLadder I was used once as this contained the length of bands 
necessary to compare against our samples.  
With the gel run and visualised under UV light, it was apparent that all trials were 
successful as a band of approximately 4500 base pairs was shown. 
Shown on figure 4 are the markers at 4000 and 5000 bp with trial 1 highlighted in red 
for comparison. Visualisation of the gel appeared to show the trials were successful 


































Figure 4. Ethidium Bromide stain of a DNA Agarose Gel for modified PGEM-3ZF 
vector (including up_f and up_r spacers). Samples were prepared via digestion of the 
BamHI and EcorI sites at 37oC for 2 hours, where they were then ligated with the 
annealed oligonucleotides of up_f and up_r at 18oC, overnight. Samples were then 
used to transform competent cells, grown and purified. Each 50μl sample was loaded 
into a well on a 1% Agarose gel which was run at 80V for 45 minutes. Our sample was 
expected to be ~4700bp in size. The gel was visualised under UV light, with all trials 




 Modified PGEM 3ZF & Modified Luciferase Ligation 
 
With the presence of a band at 4500 bp, the next step was to ligate the modified 
luciferase gene into the target vector to complete the construction of the final 
Plasmid. 
 
In order to prepare the modified PGEM 3ZF for the insertion the Luciferase gene, a 
BamHI & HinDIII restriction digest took place so that the gene would be positioned 
perfectly. 
This point is where the deletion of spacers in Luciferase took place. The second 
BamHI site in the modified Luciferase was also digested leading to the erroneous 
deletion of 30 bases, an amount that would go unnoticed on a subsequent DNA 
Agarose gel. 
 
With the Ligation of the two constituent parts complete, the final Plasmid was used in 
a transformation and run on a DNA Agarose gel, with the expectation of seeing a 
band at just under 5000 base pairs. 
DNA HyperLadder I was used once as this contained the length of bands necessary 
to compare against our samples. With the gel run and visualised under UV light, it 
was apparent that all but one of trials were successful as a band of approximately 
5000 base pairs was shown (see figure 5).   
 
Important to note is the presence of smaller bands further down the gel which were 
theorised to be a result of the erroneous digestion of the sample by the second 
BamHI site. 
 
With the presence of the larger 5000 base pair bands, trials 1, 4 and 9 (highlighted in 
red) were selected for sequence analysis which would later reveal the extent of the 









Figure 5. Ethidium Bromide stain of a DNA Agarose Gel for modified PGEM-3ZF 
vector containing all spacers and Luciferase gene. Samples were prepared via 
digestion of the BamHI and HinDIII sites at 37oC for 4 hours, where they were then 
ligated with the modified Luciferase gene at 18oC, overnight. Samples were then used 
to transform competent cells, grown and purified. Each 50μl sample was loaded into a 
well on a 1% Agarose gel which was run at 80V for 45 minutes. Our sample was 
expected to be ~5000bp in size and all but one trial appeared to be successful. The 
gel was visualised under UV light, with trials 1, 4 and 9 selected for sequencing 
(highlighted in red). 







Having identified the issue with the Plasmid which lead to a deletion of 30 bases 
(See figure 6), we designed a new set of spacers which would be re inserted to 
position the 6x Histidine tag (when translated) correctly. 
When designing the original sequence, two BamHI sites had been erroneously 
inserted into the construct meaning that some of the new bases added in were being 
excised again when digested. While this was an unfortunate error, it was fairly 
straight forward to repair the construct by designing new oligonucleotides that 




In retrospect, an initial sequence study of the designed oligonucleotides should have 
been undertaken as this would have identified this kind of problem and prevented it 
from occurring. However as stated before, this was fortunately only a small issue and 
it was easily fixed. 
The Plasmid was digested by BamHI and submitted to a standard PCR amplification 
cycle in an attempt to clone in the correct Oligonucleotides. However this was 
unsuccessful on multiple samples so a different approach was considered. 
As the error happened at the beginning of the Plasmid, we could fortunately attempt 
to clone in the fragment using the M13F primer as well as the BV_3 oligonucleotide. 
Oligonucleotide Sequence (5’ – 3’) 
BV_5 GATCTGGAGGGGGCGGGTCTGGCGGGGGCG (30) 
BV_3 GATCCGCCCCCGCCAGACCCGCCCCCTCCA (30) 
BV_check GAGATGTGACGAACGTGTACATCG (24) 
Table 3. Table showing the sequence of the primers added to the incomplete Plasmid. 
These sequences would be used to re insert spacers into the Plasmid so that the 6x 
Histidine tag was a suitably placed in the Ribosomal exit tunnel. Numbers in brackets 
are the total number of bases per sequence listed in 5’ to 3’ order. 
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Subsequent DNA Agarose gel analysis revealed that this had indeed been 
successful (see figure7) as all 7 trials showed a strong band at around 5000 base 
pairs. An example of this is highlighted in Red on the figure. 
Note the presence of some bands at the top and bottom of the gel which were 
theorised to be heavy and light primer dimers, causing contamination. 
Similarly to the previous attempts, we could not be completely sure that the Plasmid 
was fully repaired until a sequence analysis was completed. By doing this, we could 
show a map of the Plasmid, including all of the relevant sites (see figure 8).  
  
Figure 6. Plasmid map of the incomplete Vector, highlighting the errors discussed. 
Note that this INCLUDES the spacers that were deleted, to show where in the Plasmid 
the deletion occurred. 
A key feature highlighted are the two BamHI sites, one of which was erroneously 
inserted at position 60 and 90. In the final construct, the second of these sites was no 
longer present. 









Markers Trial 1 Trial 2 Trial 3 Trial 4 Trial 5 Trial 6 Trial 7 
Figure 7. Ethidium Bromide stain of a DNA Agarose Gel for modified PGEM-3ZF 
vector containing all spacers and Luciferase gene. This is the completed repair of the 
construct, to re-insert missing bases incorrectly removed through erroneous BAMHI 
insertion. Samples were prepared via digestion of the BamHI site at 37oC for 4 hours, 
where they were then used in a PCR amplification with M13F Primer and BV_3.  
Full cycles completed were 1x Denaturation (96oC/5 minutes) 30x Elongation (96oC/45 
seconds, 50oC/45 seconds and 72oC/1 minute) and 1x Final Extension (72oC/5 
minutes) with the samples being held at 5oC thereafter. 
Each 50μl sample was loaded into a well on a 1% Agarose gel which was run at 80V 
for 45 minutes. Our sample was expected to be ~5000bp in size and all trials 
appeared to be successful. The gel was visualised under UV light, with trial 1 (red box) 




Figure 8. Plasmid map of the fully complete Vector, preliminarily named “Bradley 1” 
highlighting key features of the Plasmid. 
All key features that have been necessary to build this Plasmid are shown, including 
the T7 promoter, Ampicillin resistance gene, M13F & R primers and all Restriction 
enzyme sites. 
A total length of 4878 nucleotides is shown, achieved with the re insertion of new 




 Luciferase Assays (and RNA synthesis) 
As discussed in section 4.1 of materials and methods, RNA synthesis was attempted 
in vitro but no discernible data was able to be collected. In total, 4 trials were 
attempted and the samples collected were tested on a Nanodrop to ascertain their 
concentrations. 
Trial 1: 0.23 μg/ml 
Trial 2: 0.22 μg/ml 
Trial 3: 0.17 μg/ml 
Trial 4: 0.14 μg/ml 
As shown, these concentrations are exceedingly low and with this data, it was 
decided that a coupled reticulocyte lysate system would be used instead. 
Initially, the activity of the Luciferase gene needed to be confirmed. By measuring 
Luminescence, we could ascertain that the Luciferase gene was active and that it 
was actively degrading Luciferin to produce light as a by-product. As shown in Figure 
9 an average Bioluminescence of 15.66 was given for the control Plasmid (without 
Luciferase) showing that the substrate was not degraded. Conversely, an average of 
370 was given for the “Bradley 1” Plasmid, showing that the gene was active and 
that with the substrate being degraded, light was being emitted. 
To test this fully, a control was set up containing the full amino acid mixture ensuring 
that Luciferase could be produced and the substrate digested. Measurement was 
once again taken via Bioluminescence, with the expectation being to compare 
arrested translation with the control. To ensure reliability, the test was completed in 
triplicate with a t-test being used to interpret the data and a bar graph to visualise the 
data (Figure 9). 
Data processing revealed that the T-Statistic of this triplicate was -33.97 and the  
P Value was 0.000432636. Note that the negative of T-Statistic two tail was -4.03, 
with the T-Statistic being significantly less than that. This analysis allowed us to 
conclude that the data sets were independent of one another, that is the Plasmid is 

























Control (-Luciferase) With Luciferase
Figure 9. Bar graph representation of Luciferase assay on modified PGEM 3ZF and 
unmodified PGEM 3ZF (without Luciferase gene) to compare the activity of Luciferase on 
its substrate. Measurement was completed in the form of Bioluminescence which would 
be present with the degradation of substrate by Luciferase. The graph indicates that 
without the Luciferase gene present, there is no Bioluminescence above background 
readings (Blue) whereas the modified vector shows an average reading of 370 (Red). 
Error bars have been included in the representation of the data to indicate the precision of 
data collected. This data was collected to ensure that the modified construct contained 
active Luciferase, which would be further used in the project. 
The table of raw data shows the control and Plasmid trials highlighted in red, with the 




 1 2 3 4 5 6 7 8 9 10 11 12 
A 17 18 19 18 17 19 15 16 28 49 28 16 
B 19 18 12 17 14 16 13 27 376 384 350 14 
C 18 20 14 9 17 17 18 13 11 14 16 13 
D 20 22 24 13 12 19 12 16 19 16 22 12 
E 16 14 20 12 12 14 19 14 16 11 18 14 
F 17 12 17 20 19 18 12 15 16 13 11 13 
G 20 19 13 10 13 18 15 13 17 13 16 14 







Using the data described in Table 4, the Standard deviation for the control was 
shown to be 3.21 and the Standard deviation for the Plasmid was 17.78. 
This indicates that the spread of the data is low and can be considered more reliable 
as the data lies close to the average. 
 
These figures were also used to calculate the standard error used in the visual 
representation of the error bars (all done electronically). 
In this experiment, Relative Light Units are given as there is not a specific unit for the 
Bioluminescence of Luciferase. The detection of light is as a result of the 
proportional expression of the Luciferase gene which shows that the higher the 
detection, the more the gene is being expressed. 
With this data analysis, we concluded that the Luciferase gene in the Plasmid was 
active. We could reliably state this conclusion thanks to a significant disparity 
between the T-Statistic and the negative of T-Statistic 2 tail. Moreover, the P value 
being so low showed that this was highly unlikely to have happened by chance.  
To test this conclusion fully, as well as begin testing if Translation could be arrested, 
a further experiment was conducted, this time with and without the presence of 
Table 4. Table showing the raw data of the Luciferase assay on modified PGEM 3ZF 
and unmodified PGEM 3ZF (without Luciferase gene). Highlighted in red are the data 
points where the reaction occurred. All other cells recorded the luminescence for 
purposes of comparison. All data is in Relative Light units (RLU). The average 
Bioluminescence for the control was 15.66 RLU and the average Bioluminescence for 
the Plasmid was 370 RLU. 
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Leucine. A control was set up containing the full amino acid mixture ensuring that 
Luciferase could be produced and the substrate digested. Measurement was once 
again taken via Bioluminescence, with the expectation being to compare arrested 
translation with the control which did contain Leucine, therefore allowing Translation 
to take place and Luciferin to be broken down. 
To ensure reliability, the test was once again completed in triplicate with a T-test 
being used to interpret the data and a bar graph to visualise the data (10). 
Data processing revealed that the T-Statistic of this triplicate was -9.15 and the  
P Value was 0.000396. Note that the negative of T-Statistic two tail was - 
2.776445105, with the T-Statistic being less than that. Moreover, the P-value being 
so low confirmed that this could not have happened by chance. 
This analysis allowed us to conclude that the data sets were independent of one 
another, showing that without the presence of Leucine, Translation could potentially  
be arrested. Conversely, the control confirmed once more that Translation could 
occur in this system as shown by the high readings for Luminescence. It is important 
to realise that this does not unequivocally prove that cell death has not occurred and 
























Without Leucine With Leucine
Figure 10. Bar graph representation of Luciferase assay on modified PGEM 3ZF (containing 
Luciferase) with and without the presence of Leucine in the amino acid mix, to compare the 
activity of Luciferase on its substrate. Measurement was completed in the form of 
Bioluminescence which would be present with the degradation of substrate by Luciferase. 
This was completed in triplicate with a standard deviation being calculated as well as 
conducting a t-test. 
The control indicated that without Leucine being present, translation would not occur, leading 
to the substrate not being digested and thus no discernible Bioluminescence was detected 
above background (Blue). 
The trials that did contain Leucine indicated that translation was occurring as an average 
Bioluminescence of 571.6 was detected as the substrate was indeed being digested (Red). 
The table of raw data shows the control and Plasmid trials highlighted in red, with the control 
being that of Row B 9 – 11. 
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 1 2 3 4 5 6 7 8 9 10 11 12 
A 96 139 142 133 131 117 119 109 150 155 136 106 
B 150 213 127 146 115 113 108 149 622 592 501 108 
C 116 116 124 122 120 132 128 119 112 139 105 132 
D 124 157 109 126 107 133 92 133 107 120 109 129 
E 118 123 148 122 133 103 112 109 141 117 125 79 
F 127 116 115 123 101 103 118 111 136 111 98 109 
G 117 120 104 97 124 106 114 123 110 105 114 99 







Using the data from Table 5, the Standard deviation for the control was shown to be 
63.01 and the Standard deviation for the Plasmid was 45.18. It must be noted that 
there is a higher spread between the data points in this experiment however it was 
still far within an acceptable range. Additionally, the background readings indicated 
by the Control are shown to be higher across the entire experiment which was a 
result of the use of a different piece of equipment due to the previous one being 
unavailable. 
 
These figures were once again used to calculate the standard error used in the 
visual representation of the error bars (all done electronically). 
With this data analysis, we concluded that Translation was being arrested without 
the presence of Leucine. We could reliably state this conclusion thanks to a 
significant disparity between the T-Statistic and the negative of T-Statistic 2 tail. 
Moreover, the P value being so low showed that this was highly unlikely to have 




Table 5. Table showing raw data of Luciferase assay on modified PGEM 3ZF 
(containing Luciferase) with and without the presence of Leucine in the amino acid mix. 
Highlighted in red are the data points where the reaction occurred. All other cells 
recorded the luminescence for purposes of comparison. All data is in Relative Light 
units (RLU). The average Bioluminescence for the control was 571.66 RLU and the 




In order to progress our understanding of translation, this project sought to begin 
development of new reagents to be used in single molecule systems. The most 
important of these reagents, was a stable plasmid, whose parameters are easily 
characterised. A well characterised Plasmid expressing a heavily documented 
protein, in this case Luciferase, would enable us to harness the power of single 
molecule experiments to ascertain a rate of Translation that could potentially be 
applied to existing computational models. While we have successfully created a 
stable Plasmid capable of expressing Luciferase, which has been verified by means 
of a Luciferase assay, we have fallen short of unequivocally establishing that 
Translation can be arrested in this system and as such further work will be needed to 
verify this. 
The initial design of the plasmid centred on choosing a well characterised protein 
that is easy to use and investigate. For this purpose, Luciferase was chosen, which 
along with the designed spacers, would have a Leucine codon at position 17, 
meaning that it would be a sufficient distance from the 6x Histidine complex vital for 
analysis. In this model, the Leucine codon would be our arrest codon, where 
translation is arrested, allowing further analysis of the interactions between mRNA, 
Ribosomes and tRNA:Amino acid complexes. By having this codon a sufficient 
distance from the Histidine tag, we could purify our mRNA:ribosome complex to give 
pure active Ribosome fractions.  
Vitally, however, with translation being arrested, we could insert fluorescently tagged 
tRNA:Leucine and monitor the system, in real time, using single molecule 
techniques. 
In order to reach this stage several steps were taken to ensure that a stable and 
functional DNA Plasmid was designed and created. Although an initial oversight had 
led to the erroneous deletion of the spacers, this was quickly noticed and rectified 
through the insertion of the missing sequence using PCR cloning techniques.  
With the Luciferase gene being present in our Plasmid, it was important to measure 
its activity as a baseline for all future attempts at translation. This was achieved 
using a coupled Rabbit reticulocyte system that would complete both transcription 
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and translation simultaneously. In addition to this, the kits used allowed us to tailor 
the amino acid mixtures available to omit Leucine completely. 
Initial testing confirmed that against unedited PGEM 3ZF, our construct was in 
working order, able to produce Luciferase under regular conditions. The degradation 
of the Luciferin substrate emits light28 as one of its products and this was measured 
in the form of Bioluminescence, which was indeed identified in trials with the 
Luciferase containing Plasmid. 
Further analysis would show us that the removal of Leucine from the amino acid 
mixture could potentially halt translation. While this is assumed an obvious 
consequence of the action, it is none the less paramount that this was investigated 
as it formed one of the pillars of future analysis. However, it is important to note that 
this needs to be fully confirmed through further testing. In order to establish that 
Translation has in fact, arrested and that cell death has not occurred, we must test to 
see if Translation can be continued if Leucine is placed back into the system. At this 
stage, it cannot be unequivocally confirmed that only Translation has arrested, 
merely that the removal of Leucine prevents further Translation from occurring. 
 With the data being quantified by means of a t-test, we could see the reliability of 
concluding that the removal of Leucine would halt translation in this initial test. T-stat 
was shown to be -9.15 and a P value of 0.000396 was given. These values together 
not only indicated that the hypothesis could be accepted but also that this was 
statistically unlikely to have happened by chance. 
This is not enough to be certain that cell death has not occurred. In order to verify 
that Translation can be resumed, Leucine must be placed back into the system and 
analysed for the emittance of light (an indicator that Translation has occurred). 
Moreover, an additional test that can be attempted is a purification of the system to 
allow for an SDS PAGE analysis to verify a partial production of protein. Subsequent 
Western blotting would be possible due to the exposed Histidine tag on the protein 
and the expectation would be to see a band of around 6kDa. This is doubly important 
as it would also confirm that at the arrested stage of Translation, the His tag can be 




If we can validate that Translation is arrested and can be restarted, we will be able to 
then move onto single molecule study of this system, which will help to yield data on 
the kinetics of Translation in further detail. One such recent experiment established 
the effect that tRNA amino acylation exerts on the rate of Translation. The 
development of a model allowed the prediction of the way that heterologous genes 
can influence expression and thereby Translation at the cellular level. 
Other research has indicated that it is also possible to deduce in vivo Translation 
rates from in vitro gathered data. The developed computational model uses data 
gathered on the time take for each individual step to estimate the rate of protein 
synthesis based on existing models29. This new computational model was compared 
against independent sets of in vivo data on protein synthesis which found it to be 
highly accurate30-32. This data is significant to this project as it will enable us to 
compare our rate of translation against existing data and evaluate its significance. 
Moreover, by characterising each step in greater detail, we could further expand 
these models to be able to move closer to defining a rate for other Translation 
processes more accurately. 
Future work 
With the plasmid being confirmed as producing our desired Protein, Luciferase, a 
strong base has been set up from which further experimentation can take place. 
Further progress must be made in order to verify that Translation has arrested and 
that Ribosomes can be purified from the arrested solution. 
The first port of call will be to rigorously test the Vectors ability to resume Translation 
after it has been arrested and confirm that cell death has not occurred. This is a 
straightforward process and can be achieved by adding 1μl of the amino acid mix 
that contains Leucine (the omitted amino acid) as well as another 25μl of the 
substrate and analysing the plate. If Translation has successfully restarted, there 
should be a clear signal of Bioluminescence detected. Subsequent purification and 
Western Blotting should reveal a Protein of approximately 61kDA in size which would 




Furthermore, it could be important that a reliable protocol is established to produce a 
large volume of pure mRNA from this Plasmid. This would help to save time and 
money as this can be done relatively cheaply in comparison to the coupled system 
used for initial analysis. However, it is important to note that there are a variety of 
parameters that would need to be evaluated and noted, including (but not limited to) 
the concentration of nucleoside triphosphates (NTP), the addition of DTT (to stabilise 
sulfhydryl groups) and the addition of RNAse inhibitor (and subsequent purification to 
remove this). If these parameters can be established easily, the RNA can be 
identified on a Urea gel, using cDNA as a marker. 
 
Moreover, in order to visualise the arrested mRNA:Ribosome complex, a light source 
would need to be established and inserted into the system. This could be achieved 
through the insertion of fluorescent amino acids into the system, through PCR, which 
could result in the creation of a scaffold to which the complex could attach. 
Furthermore, the light source is essential for all other single molecule analysis and 
so this work must be completed before furthering our work. 
In order to purify the arrested mRNA:Ribosome:Protein complex, the Histidine tag 
will be used. As the Histidine tag is sufficiently before the first Leucine codon in 
Luciferase, it will have already been translated. Thus, the Histidine tag will be 
protruding from the Ribosomal exit tunnel, enabling purification to take place. This 
could take the form of Ni-NTA chromatography. By using a Nickle charged affinity 
resin, we can bind the HIS tag to the column meaning that the Ribosomes can be 
eluted, as well as the mRNA in separate fractions. Crucially, this form of purification 
can be done in both native and denaturing conditions, meaning that a more reliable 
protocol could be established. 
If a model can be established using the combination of single molecule experiments 
and computational modelling, we will be able to predict a rate of Translation as well 
as identify rate limiting steps and their impact on the process. This development 
could be vital in enhancing our understanding of genetic diseases such as 
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